常州市存仁生物工程有限公司

产品 > 抑制剂 > > LY335979
产品名称 : LY335979
型号 : CRY905
CAS : 167354-41-8
 放大                   返回
←[上一个产品]              [下一个产品]→


产品详细:
Description of:LY335979
LY335979 significantly enhanced the survival of mice implanted with Pgp-expressing murine leukemia (P388/ADR) when administered in combination with either daunorubicin, doxorubicin or etoposide. Coadministration of LY335979 with paclitaxel compared to paclitaxel alone significantly reduced the tumor mass of the Pgp-expressing UCLA-P3.003VLB lung carcinoma in a xenograph model. 

Theoretical analysis:LY335979
M.Wt: 527.6
Formula: C32H31F2N3O2
Solubility: Unknown
Purity: >99%
Storage: at -20
CAS No: 167354-41-8

Availability and price:LY335979
Pakage:25mg/50mg/100mg/250mg/500mg/1g/5g
Stock : in stock
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to :
orders@chemrenblock.com
Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days


相关产品 :
Vipadenant(BIIB 014)
Vipadenant(BIIB 014)
Fetzima
Fetzima
ONO-4059
ONO-4059
SB-705498
SB-705498
Evacetrapib
Evacetrapib
PF 573228
PF 573228
Deracoxib(地拉考昔)
Deracoxib(地拉考昔)
Defactinib(VS-6063)
Defactinib(VS-6063)